NSE · Healthcare · updated 16 Oct 2026, 11:11 pm IST
From the exchange's bulk and block deal disclosures and NSE's daily file. The client's kind is read from its name. A record of trades, not a view on them. All big deals →
Healthcare · SMALLCAP · in NIFTY 500, NIFTY SMALLCAP 250 · sector page
Neuland Laboratories Ltd. trades on the NSE under the symbol NEULANDLAB and is classified under Healthcare (smallcap cap by NSE's index grouping). It is a constituent of NIFTY 500, NIFTY SMALLCAP 250. NSE's securities master records its listing date as 13 Oct 2008.
On 16 Oct 2026 the stock closed at ₹19,675, -1.4% on the day. Over the past year it has traded between ₹10,487.3 and ₹23,995; the current price sits 68% of the way up that range, 18.0% below the 52-week high. The move has been -5.8% over five sessions, -13.9% over a month, +6.1% over three months, +31.1% over six months.
Volume in the last session was 0.6× the stock's 20-session average. 38% of that volume was taken as delivery, against a 20-session average of 49%.
No promoter or insider trades have been filed for the stock in the last 90 days. No bulk or block deals were disclosed in the last 30 days.
Among 13 Healthcare stocks tracked here, its one-month return ranks 11th; the strongest over the month was Cohance Lifesciences Ltd. (+6.0%).
| Face value | ₹10 |
| ISIN | INE794A01010 |
| 52-week range | ₹10,487.3 – ₹23,995 |
| 1-month return | -13.9% |
| 3-month return | +6.1% |
| 6-month return | +31.1% |
| Delivery (last session) | 38% (avg 49%) |
| Insider filings (90d) | 0 buy / 0 sell |
| Disclosed deals (30d) | 0 buy / 0 sell |
Max Healthcare Institute Ltd. -19.4% · Biocon Ltd. -9.3% · Piramal Pharma Ltd. -5.0% · Fortis Healthcare Ltd. -16.9% · Viyash Scientific Ltd. -9.5% · Dr. Reddy's Laboratories Ltd. +4.1% · Marksans Pharma Ltd. -2.9% · Zydus Lifesciences Ltd. -3.2% · Sun Pharmaceutical Industries Ltd. -4.3% · Laurus Labs Ltd. +5.4% · all Healthcare stocks
After a week with one small new issue, October's fundraising depends almost entirely on Jio Platforms, whose reported size is about twenty times that of Paras Healthcare. In Tonbo Imaging's case all proceeds go to…
Crude below $100 eases the import bill and the input costs of oil marketers, airlines, paints and chemicals, which is why Reliance, IndiGo and Asian Paints were among the gainers. Banks and consumer names moved on…
Two listed groups sit on either side of this. Health and general insurers would pay out less per claim, which is the industry's stated aim: it blames hospital billing inflation for rising claim costs and premiums…
Close price
Delivery % · 30-session average 44.8%
Delivery is the share of traded volume actually settled into demat accounts rather than squared off intraday — the difference between accumulation and churn. How it is used.
Exchange-disclosed transactions, reported as published.
| Date | Client | Type | Qty | Price | Value |
|---|---|---|---|---|---|
| No deals disclosed. | |||||